Hinde El Otmani/ISTH
Oct 16, 2025, 04:37
Hinde El Otmani’s Team Explores Plasmin-Mediated Proteolysis of von Willebrand Factor in Acutely Ill Patients
RPTH Journal shared on LinkedIn:
”Elevated von Willebrand factor (VWF) is common in liver disease, but its regulation remains unclear.
The latest study from Hinde El Otmani explores how plasmin-mediated VWF cleavage may lead to microvascular changes in acutely ill patients.
Check it out here.
Co-authors: Ton Lisman, Coen Maas, Marilena Stamouli, Jelle Adelmeijer”
Read the full article in RPTH.
Article: Plasmin-mediated proteolysis of von Willebrand factor in patients with acute and chronic liver disease
Authors: Hinde El Otmani, Marilena Stamouli, Jelle Adelmeijer, William Bernal, Coen Maas, Vishal C. Patel, Ton Lisman
Stay updated on all scientific advances in the field of thrombosis with Hemostasis Today.
-
Jan 22, 2026, 15:36We Must Roll Up Our Sleeves And Help: José Antonio García Erce on Plasma Donation
-
Jan 22, 2026, 15:25Nita Radhakrishnan on Challenges In Congenital Afibrinogenemia
-
Jan 22, 2026, 15:10Jin Q Gives a Summary of 2025’s Most Impactful Cell and Gene Therapy Milestones
-
Jan 22, 2026, 14:57Nirav Dhanesha on CD14 Acting As A Functional Driver of DVT
-
Jan 22, 2026, 11:41Jamilla Goedegebuur and Colleagues on VTE Management in Case of PAD
-
Jan 22, 2026, 11:28Abdulrahman Katib on API-CAT Trial’s Evaluation of Apixaban Dosing
-
Jan 22, 2026, 11:19Bruno Odisio: Ablation Margins Are Software-Dependent
-
Jan 22, 2026, 10:38Pedro Perez: The VTE Market Is Clearly Entering Its Next Phase
-
Jan 22, 2026, 10:29Marvin Garcia Reyes Presents a Case of Aorto-Visceral and Aorto-Iliac Thrombosis